the positive ana confirms the diagnosis so no further evaluation is necessary pancytopenia
DESCRIPTION
** You are asked to see a 24 y/o female with fatigue, myalgias , and a positive ANA. Which of the following would NOT be consistent with SLE?. The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/1.jpg)
** You are asked to see a 24 y/o female with fatigue, myalgias, and a positive ANA. Which of the following would NOT be consistent with SLE?
a) The positive ANA confirms the diagnosis so no further evaluation is necessary
b) Pancytopeniac) A history of a transient episode of confusion followed
by numbness and tingling in the right armd) No history of arthritise) Significant cardiomegaly on chest x-ray
![Page 2: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/2.jpg)
Immune Mediated Disease
Etiology - unknown Multiple organ system involvement Immune complexes
ANAComplementOther antibodies
Treatment - usually corticosteroids
![Page 3: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/3.jpg)
![Page 4: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/4.jpg)
![Page 5: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/5.jpg)
![Page 6: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/6.jpg)
Systemic Lupus Erythematosus Multisystem disease - young female Antigen-antibody complexes
positive ANA, dsDNA, complement Common problems
Arthritis, dermatitis, hematologic, renal, polyserositis, CNS, splenomegaly
Treatment - corticosteroids
![Page 7: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/7.jpg)
Lupus Demographics young women 5:1 over men ages - 15 - 40 Relatively uncommon – 50/100,000 individuals - 0.05%
population Males, Afro-Americans (increased Sm/RNP), Hispanics have
worse prognosis Genetic factors – variable
High prevalence among twins5-12% cumulative incidence among first-degree relativesHLA Class II (multiple associations) and C4a null alleles
![Page 8: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/8.jpg)
Typical findings Skin - butterfly rash, alopecia, photosensitivity, mucosal
ulcerations Arthritis - 90%, symmetrical CNS - 25-50%
focal vs. general, headache most common Serositis - pericardial, pleural, peritoneal CV – Increased incidence of atherosclerotic plaques Splenomegaly
![Page 9: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/9.jpg)
![Page 10: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/10.jpg)
![Page 11: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/11.jpg)
Atherosclerotic plaque (controls vs. SLE patients)(controlled for corticosteroid use)
NEJM 349:2003, 2399-2406
![Page 12: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/12.jpg)
![Page 13: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/13.jpg)
SLE - Renal Disease – 50% (acute vs chronic)
Normal - I Minimal change - IIA Mesangial - IIB Focal Proliferative - III Diffuse Proliferative - IV Membranous - V Sclerosis - VI
WHO Classification
![Page 14: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/14.jpg)
Diffuse Proliferative Focal Proliferative
Membranous Mesangial
![Page 15: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/15.jpg)
SLE - Classification criteria(4 of 11 criteria should be present) Malar rash Discoid rash Photosensitivity Oral Ulcers Arthritis Serositis
Renal disorder Neurologic disorder Hematologic disorder Immunologic disorder ANA positive
1997 update of the 1982 revision of the ACR classification criteria for SLE
![Page 16: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/16.jpg)
MS Core - 2008
orAPL antibody
![Page 17: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/17.jpg)
![Page 18: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/18.jpg)
![Page 19: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/19.jpg)
Systemic Lupus - Laboratory Findings Serology
ANA - 95% (nDNA 50%, Sm 50%)Rheumatoid factor - 15-25% Complement - 50-75%
CBCLeukopenia - 50%Anemia - 50-75%Thrombocytopenia - 10-20%
![Page 20: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/20.jpg)
Autoantibodies in Rheumatic Diseases
SLE DS DNA, Sm
Drug induced SLE HistoneSCLE Anti Ro (SS-A)
MCTD RNP
Scleroderma Scl-70
CRST Centromere
Polymyositis/Dermatomyositis Jo-1 (histadyl tRNA synthetase)
Sjogren’s Syndrome SS-A, SS-B
Wegener’s Granulomatosis cANCA (Proteinase 3)
See appendix for more information
![Page 21: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/21.jpg)
![Page 22: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/22.jpg)
Lupus Erythematosus - Subtypes SLE - systemic Discoid – relatively benign (skin and joints) SCLE - subacute cutaneous
anti-Ro antibody positiveneonatal lupus / congenital heart block
Drug induced – anti-histone antibody Anti-phospholipid antibody syndrome
![Page 23: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/23.jpg)
![Page 24: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/24.jpg)
![Page 25: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/25.jpg)
![Page 26: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/26.jpg)
![Page 27: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/27.jpg)
Drug-Induced Lupus Major drug associations
HydralazineProcainamide
Less common associationsAlpha methyldopa, Diphenylhydantoin, PTU, PCN, Sulfa, INH, BCP, Minocycline, anti-TNF
Antibody associationAnti-histone antibody
![Page 28: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/28.jpg)
Anti-phospholipid Syndrome - lupus anticoagulant / anticardiolipin antibody
Increased clotting Screening - PTT, False + VDRL Associated with SLE - 30% of cases Anti-cardiolipin antibody may be present Treatment - anticoagulation
![Page 29: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/29.jpg)
Anti-phospholipid Syndrome Classification criteriaOne clinical and one lab criteria must be found Clinical (either of following)
Vascular thrombosis – one or more episodes of arterial, venous, or small vessel thrombosisPregnancy morbidity
– Late term (>10 wk) abortion (normal fetus)– Premature birth (<34 week) with preeclampsia, eclampsia, or placental insufficiency– Three or more spontaneous abortions (<10 weeks) without other explanation
Abnormal lab (either test)Anticardiolipin antibody (IgG or IgM) X2 twelve weeks apart and not more than 5 years previously (must be moderate or high titer)Anti-β2 glycoprotein (IgM or IgG) - >99%ileLupus anticoagulant (prolonged PTT with failure to correct) x2 twelve weeks apart
![Page 30: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/30.jpg)
![Page 31: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/31.jpg)
![Page 32: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/32.jpg)
![Page 33: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/33.jpg)
SLE - treatment Nonsteroidals Corticosteroids - major organ dysfunction Antimalarials - Hydroxychloroquine skin and joint
manifestations (minor organ systems) Cytotoxics (CTX) - major renal involvement
high dose monthly IV (750-1000 mg/m2)OR
Daily oral (100-150 mg/d)
Mycophenolate mofetil
![Page 34: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/34.jpg)
Mycophenolate Mofetil (MMF) Inhibits lymphocyte proliferation (both B and T cells) Inhibits glycosylation of adhesion molecules Relatively non toxic
![Page 35: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/35.jpg)
Prognosis SLE
0102030405060708090
100
Initial 1 year 5 years 10 years
Perc
ent s
urvi
val
Pre-steroids Steroids Immunosup. Currently
95% 10 year survival
![Page 36: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/36.jpg)
You are asked to see a 24 y/o female with fatigue, myalgias, and a positive ANA. Which of the following would NOT be consistent with SLE?
a) The positive ANA confirms the diagnosis so no further evaluation is necessary
b) Pancytopeniac) A history of a transient episode of confusion followed
by numbness and tingling in the right armd) No history of arthritise) Significant cardiomegaly on chest x-ray
![Page 37: The positive ANA confirms the diagnosis so no further evaluation is necessary Pancytopenia](https://reader035.vdocuments.us/reader035/viewer/2022062520/568163c2550346895dd4e6ee/html5/thumbnails/37.jpg)
A 18 y/o female presents with a five month history of joint complaints, easy bruisibility, pain with breathing on the left side, and occasional weakness in the left hand and right foot. Which of the following would you NOT expect to find on further evaluation?
a) Positive VDRL test for syphilisb) History of previous miscarriagec) Recurrent oral ulcerationsd) 3+ proteinuria on UAe) History of allergy to multiple medications